Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA134001
Max Phase: Preclinical
Molecular Formula: C6H12O5S
Molecular Weight: 196.22
Molecule Type: Small molecule
Associated Items:
ID: ALA134001
Max Phase: Preclinical
Molecular Formula: C6H12O5S
Molecular Weight: 196.22
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: OC[C@H]1S[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Standard InChI: InChI=1S/C6H12O5S/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3-,4+,5-,6+/m1/s1
Standard InChI Key: KNWYARBAEIMVMZ-DVKNGEFBSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 196.22 | Molecular Weight (Monoisotopic): 196.0405 | AlogP: -2.50 | #Rotatable Bonds: 1 |
Polar Surface Area: 101.15 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 5 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 12.41 | CX Basic pKa: | CX LogP: -2.62 | CX LogD: -2.62 |
Aromatic Rings: 0 | Heavy Atoms: 12 | QED Weighted: 0.32 | Np Likeness Score: 1.08 |
1. Pastor M, Cruciani G, Clementi S.. (1997) Smart region definition: a new way to improve the predictive ability and interpretability of three-dimensional quantitative structure-activity relationships., 40 (10): [PMID:9154968] [10.1021/jm9608016] |
2. Pan D, Liu J, Senese C, Hopfinger AJ, Tseng Y.. (2004) Characterization of a ligand-receptor binding event using receptor-dependent four-dimensional quantitative structure-activity relationship analysis., 47 (12): [PMID:15163189] [10.1021/jm030586a] |
3. Gohlke H, Klebe G.. (2002) DrugScore meets CoMFA: adaptation of fields for molecular comparison (AFMoC) or how to tailor knowledge-based pair-potentials to a particular protein., 45 (19): [PMID:12213058] [10.1021/jm020808p] |
4. Dumas DP, Ichikawa Y, Wong C, Lowe JB, Nair RP. (1991) Enzymatic synthesis of sialyl Lex and derivatives based on a recombinant fucosyltransferase, 1 (8): [10.1016/S0960-894X(00)80270-X] |
5. So SS, Karplus M.. (1997) Three-dimensional quantitative structure-activity relationships from molecular similarity matrices and genetic neural networks. 2. Applications., 40 (26): [PMID:9435905] [10.1021/jm970488n] |
6. Uddin R, Saeed M, Ul-Haq Z. (2013) Molecular docking- and genetic algorithm-based approaches to produce robust 3D-QSAR models, [10.1007/s00044-013-0812-0] |
Source(1):